Tandem Diabetes Care has responded to an FDA recall notice that the organization calls its "most serious" after hundreds of injuries have been reported.
Buyers of Robitussin can now apply to get money from a class-action lawsuit that began in 2022 over the cough medicine being marketed as "non-drowsy." Consumers can get $1.50 to $4.75 per claim ...
Buyers of Robitussin can now apply to get money from a class-action lawsuit that began in 2022 over the cough medicine being marketed as "non-drowsy." Consumers can get $1.50 to $4.75 per claim ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback